+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phase I study of sequential administration of varying doses of dacarbazine and fotemustine in advanced malignancies



Phase I study of sequential administration of varying doses of dacarbazine and fotemustine in advanced malignancies



Proceedings of the American Association for Cancer Research Annual Meeting 36: 218




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032786250

Download citation: RISBibTeXText


Related references

Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma. British Journal of Cancer 67(6): 1356-1360, 1993

A phase II study of the sequential administration of dacarbazine and fotemustine in the treatment of cerebral metastases from malignant melanoma. European Journal Of Cancer. 30a(14): 2093-2095, 1994

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma. Journal of Translational Medicine 11: 38, 2013

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-alpha in advanced malignant melanoma. 2013

Cisplatin + dacarbazine + fotemustine and interferon alpha-2b in advanced melanoma A phase I study. Melanoma Research 7(Suppl. 1): S43, 1997

Sequential administration of dacarbazine and fotemustine in disseminated melanoma. Proceedings of the American Association for Cancer Research Annual Meeting 32: 191, 1991

Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patients. Melanoma Research 5(6): 419-424, 1995

Phase I-II study on isolation antiblastic fotemustine perfusion after dacarbazine chemosensitization for advanced melanoma of the extremities. Melanoma Research 13(3): 293-297, 2003

Phase ii trial of the sequential administration of dtic and fotemustine in advanced malignant melanoma. Proceedings of the American Association for Cancer Research Annual Meeting 31: 200, 1990

Phase I study of sequential administration of topotecan and 5-fluorouracil in patients with advanced malignancies. Cancer Investigation 20(5-6): 644-650, 2002

Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group. Cancer 89(12): 2630-2636, 2000

Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group. Cancer 89(12): 2630-2636, 2000

Activity and unexpected lung toxicity of the sequential administration of two alkylating agents--dacarbazine and fotemustine--in patients with melanoma. European Journal of Cancer 29a(5): 711-719, 1993

Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma--an effective combination with unexpected toxicity. European Journal of Cancer 28(2-3): 447-450, 1992